Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1

被引:8
作者
Lin, Yu [1 ]
Bai, Xia [2 ]
Zhou, Weina [2 ]
He, Yulin [2 ]
Wu, Yiwei [3 ]
Wang, Xiangcheng [2 ]
机构
[1] Inner Mongolia Med Univ, Dept Ontol Radiotherapy, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China
[2] Inner Mongolia Med Univ, Dept Nucl Med, Affiliated Hosp, Hohhot 010050, Inner Mongolia, Peoples R China
[3] Soochow Univ, Affiliated Hosp 1, Dept Nucl Med, Suzhou 215000, Jiangsu, Peoples R China
关键词
Radiation; TNBC; ZEB1; ATM; Migration; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; CELLS; CARCINOMA; RADIOTHERAPY; EXPRESSION; STRATEGIES; INVASION; PATHWAY; EMT;
D O I
10.1016/j.biopha.2018.08.026
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast cancer (TNBC) cells and increase the expression of epithelial-mesenchymal transition (EMT) related transcription factor ZEB1, while had no effect on Snail, Slug or Twist. Knockdown of ZEB1 attenuated radiation induced cell migration and invasion, suggesting that ZEB1 is essential for radiation induced progression of TNBC. Radiation increased the protein stability of ZEB1, while had no effect on its mRNA expression. Particularly, the upregulation of ATM, which can phosphorylate and stabilize ZEB1, was involved in radiation induced upregulation of ZEB1. Collectively, we found that radiation can promote the migration, invasion and EMT of TNBC cells through stabilization of ZEB1 via ATM signals.
引用
收藏
页码:1624 / 1630
页数:7
相关论文
共 50 条
[31]   Oncogenic HBXIP enhances ZEB1 through Sp1 to accelerate breast cancer growth [J].
Jiang, Yang ;
Wang, Dan ;
Ren, Hui ;
Shi, Ying ;
Gao, Yufei .
THORACIC CANCER, 2018, 9 (12) :1664-1670
[32]   Perfluorooctane sulfonate (PFOS) triggers migration and invasion of esophageal squamous cell carcinoma cells via regulation of Zeb1 [J].
Liu, Yaqing ;
Li, Jian ;
Ding, Hui ;
Ge, Dahe ;
Wang, Juntao ;
Xu, Chunjin .
DRUG AND CHEMICAL TOXICOLOGY, 2022, 45 (06) :2804-2813
[33]   ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells [J].
Cho, Hyeon-Ju ;
Oh, Nuri ;
Park, Ji-Hoon ;
Kim, Kwang-Soo ;
Kim, Hyung-Keun ;
Lee, Eunbyeol ;
Hwang, Sohyun ;
Kim, Seong-Jin ;
Park, Kyung-Soon .
MOLECULAR CANCER RESEARCH, 2019, 17 (11) :2257-2266
[34]   The deubiquitinase BRCC3 increases the stability of ZEB1 and promotes the proliferation and metastasis of triple-negative breast cancer cells [J].
Huang, Qidi ;
Zheng, Shurong ;
Gu, Huayan ;
Yang, Zhi ;
Lu, Yiqiao ;
Yu, Xia ;
Guo, Guilong .
ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (04) :564-575
[35]   TRIM25 promotes oncogenic activities through regulation of ZEB1 in breast cancer [J].
Cao, Fei ;
Li, Da-Peng ;
Wang, Lei ;
Li, Min ;
Zhang, Hui ;
Tao, Min .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10) :9751-9760
[36]   RETRACTED: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation (Retracted Article) [J].
Gao, Jin ;
Yuan, Yuan ;
Zhang, Lili ;
Yu, Shaorong ;
Lu, Jianwei ;
Feng, Jifeng ;
Hu, Sainan .
CANCER CELL INTERNATIONAL, 2020, 20 (01)
[37]   The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1 [J].
Li, Yao ;
Meng, Xue ;
Luo, Yuqing ;
Luo, Shuai ;
Li, Jin ;
Zeng, Jiafei ;
Huang, Xiang ;
Wang, Jinjing .
AGING-US, 2023, 15 (18) :9809-9821
[38]   MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1 [J].
Niu, Ke ;
Shen, Wenjie ;
Zhang, Yinghui ;
Zhao, Ying ;
Lu, Yongxian .
GENE, 2015, 574 (02) :330-336
[39]   Meso-Hannokinol inhibits breast cancer bone metastasis via the ROS/JNK/ZEB1 axis [J].
Zhu, Yuan ;
Yin, Wei-feng ;
Yu, Pei ;
Zhang, Chao ;
Sun, Ming-hui ;
Kong, Ling-yi ;
Yang, Lei .
PHYTOTHERAPY RESEARCH, 2023, 37 (06) :2262-2279
[40]   Benzyl butyl phthalate (BBP) triggers the migration and invasion of hemangioma cells via upregulation of Zeb1 [J].
Cui, Shuo ;
Wang, Linlei ;
Zhao, Huafei ;
Lu, Fei ;
Wang, Weixin ;
Yuan, Zhengjiang .
TOXICOLOGY IN VITRO, 2019, 60 :323-329